Sorich, Michael - Flinders University - Department of Clinical Pharmacology

研究领域

Pharmacogenomics, pharmacogenetics, and personalised medicine Evidence-based medicine, clinical epidemiology, decision analysis, pharmacoeconomics and meta-analysis

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Mangoni, A.A., Woodman, R.J., Kichenadasse, G., Rowland, A. and Sorich, M. (2016). Anti-VEGF-induced hypertension and cancer outcomes: translating research into clinical practice. Expert Review of Precision Medicine and Drug Development, 1(2) pp. 12 5-127. [10.1080/23808993.2016.1155963] Dawson, J., Dedigama, M., Elliot, D.J., Sorich, M., Mangoni, A.A. and Rowland, A. (2016). Prolonged induction of warfarin metabolism and a paradoxical INR response in a mitral valve replacement patient receiving rifampicin for infective endocarditis. Biomedical Research and Clinical Practice, 1(2) pp. 62-65. [10.15761/BRCP.1000112] Sorich, M. and Smith, P. (2015). Editorial. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 6(15) pp. 1567-1568. [10.2174/156802606778108988] [Scopus] Polasek, T.M., Rowland, A., Wiese, M.D. and Sorich, M. (2015). Pharmacists in Australian general practice: an opportunity for expertise in precision medicine. Therapeutic Advances in Drug Safety, 6(5) pp. 186-188. [10.1177/2042098615599947] [Scopus] Rowland, A., Dias, M.M., Wiese, M.D., Kichenadasse, G., McKinnon, R.A., Karapetis, C.S., et al. (2015). Reply: Comment on ‘Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal-antibody therapy for RAS wild-type metastatic colorectal cancer’ British Journal of Cancer, [10.1038/bjc.2015.325] [Scopus] Sorich, M., Rowland, A. and Wiese, M. (2014). Pharmacogenomic substudies of randomized controlled trials: consideration of safety outcomes. Therapeutic Advances in Drug Safety, 5(2) pp. 62-66. [10.1177/2042098613520030] [Scopus] Sorich, M., Wiese, M.D. and Pekarsky, B.A.K. (2014). Cost-effectiveness of genotyping to guide treatment. Pharmacogenomics, 15(6) pp. 727-729. [10.2217/pgs.14.24] [Scopus] Wang, L., Christophersen, C., Sorich, M.J., Gerber, J., Angley, M. and Conlon, M. (2013). Increased abundance of Sutterella spp. and Ruminococcus torques in feces of children with autism spectrum disorder. Molecular Autism, 4(42) pp. 1-4. [10.1186/2040-2392-4-42] [Scopus] McKinnon, R.A., Ward, M. and Sorich, M. (2013). Pharmacogenomics in a global world series: A roadmap for Australia, prospects and challenges. Current Pharmacogenomics and Personalized Medicine, 11(4) pp. 257-259. [10.2174/187569211104140130150639] [Scopus] McKinnon, R.A. and Sorich, M.J. (2012). Personalising Medicine. Are we there yet? AQ (Australian Quarterly) 83(4) pp. 3-8. [Web Link] [Web Link] Sorich, M.J., Polasek, T. and Wiese, M. (2012). Systematic review and meta-analysis of the association between cytochrome P450 2C19 genotype and bleeding. Thrombosis and Haemostasis, 108(1) pp. 199-200. [10.1160/TH12-02-0095] [Scopus] Sorich, M. and Smith, P. (2006). Predicting Drug Metabolism In Silico. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 6(15) pp. 1567-1568. [Web Link] Sorich, M., Osborne, G.A., Jarvis, D.A., MacIntyre, P.E., Sprigg, J. and Doecke, C. (2004). Comparison of Dextropropoxyphene and Paracetamol with Paracetamol after third molar dental extractions. Journal of Pharmacy Practice and Research, 34(1) pp. 22-25. [Scopus] [Web Link